O
Onyema Ogbuagu
Researcher at Yale University
Publications - 68
Citations - 1705
Onyema Ogbuagu is an academic researcher from Yale University. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 11, co-authored 53 publications receiving 867 citations. Previous affiliations of Onyema Ogbuagu include Icahn School of Medicine at Mount Sinai & National University of Rwanda.
Papers
More filters
Journal ArticleDOI
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
Christoph D. Spinner,Robert L. Gottlieb,Gerard J. Criner,José Ramón Arribas López,Anna Maria Cattelan,Alex Soriano Viladomiu,Onyema Ogbuagu,Prashant Malhotra,Kathleen M. Mullane,Antonella Castagna,Louis Yi Ann Chai,Meta Roestenberg,Owen Tak Yin Tsang,Enos Bernasconi,Paul Le Turnier,Shan-Chwen Chang,Devi SenGupta,Robert H. Hyland,Anu Osinusi,Huyen Cao,Christiana Blair,Hongyuan Wang,Anuj Gaggar,Diana M. Brainard,Mark J. W. McPhail,Sanjay Bhagani,Mi Young Ahn,Arun J. Sanyal,Gregory D. Huhn,Francisco M. Marty +29 more
TL;DR: Among patients with moderate COVID-19, those randomized to a 10-day course of remdesivir did not have a statistically significant difference in clinical status compared with standard care at 11 days after initiation of treatment, but the difference was of uncertain clinical importance.
Journal ArticleDOI
De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report
S. Gandhi,Jon Klein,Alexander J Robertson,Mario A. Peña-Hernández,Michelle Lin,Pavitra Roychoudhury,Peiwen Lu,John Fournier,David Ferguson,S. A. Mohamed Bakhash,M. Catherine Muenker,Ariktha Srivathsan,Elsio A. Wunder,N. Kerantzas,Wenshuai Wang,Brett D. Lindenbach,Anna Marie Pyle,Craig B. Wilen,Onyema Ogbuagu,Alexander L. Greninger,Akiko Iwasaki,Wade L. Schulz,Albert I. Ko +22 more
TL;DR: In this paper , a case of an immunocompromised patient with acquired B-cell deficiency who developed an indolent, protracted course of SARS-CoV-2 infection was presented.
Journal ArticleDOI
High Prevalence of Antimicrobial Resistance Among Common Bacterial Isolates in a Tertiary Healthcare Facility in Rwanda
TL;DR: Antimicrobial resistance rates are high in Rwanda and pose a serious therapeutic challenge to the management of common infections.
Journal ArticleDOI
HIV Risk perception and eligibility for pre-exposure prophylaxis in women involved in the criminal justice system.
TL;DR: A cross-sectional survey of HIV-uninfected, cis-gender women on probation, parole and/or recently released from prison/jail to assess PrEP awareness, eligibility, potential barriers to uptake, and the PrEP care continuum found that WICJ frequently engage in HIV risk behaviors that make them eligible for PrEP.
Posted ContentDOI
De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case report
Shiv Gandhi,Jonathan Klein,Alexander Robertson,Mario A Peña-Hernández,Michelle J. Lin,Pavitra Roychoudhury,Peiwen Lu,John Fournier,David Ferguson,Shah A Mohamed Bakhash,M. Catherine Muenker,Ariktha Srivathsan,Elsio A. Wunder,Nicholas Kerantzas,Wenshuai Wang,Anna Marie Pyle,Anna Marie Pyle,Craig B. Wilen,Onyema Ogbuagu,Alexander L. Greninger,Alexander L. Greninger,Akiko Iwasaki,Wade L. Schulz,Albert I. Ko +23 more
TL;DR: In this paper, a case of an immunocompromised patient with acquired B-cell deficiency who developed an indolent, protracted course of SARS-CoV-2 infection was presented.